MMP9 and rheumatoid arthritis: Using the CytoNCA plugin to identify the key core targets (Fig. 4A), we found that EGFR, MMP9, TLR4, ESR1, MMP2, PPARG, MAPK1, JAK2, STAT1, and MAPK8 were the top 10 targets for RA treatment.